Triple-negative breast cancer (TNBC) is a highly heterogeneous disease defined by the absence of oestrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) overexpression1. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.